Eli Lilly’s weight loss drug, Zepbound, has demonstrated significant benefits in patients with heart failure and obesity, based on late-stage trial data released by the company. The findings suggest that Zepbound, along with other popular GLP-1 drugs, may offer health advantages beyond weight loss and blood sugar regulation. This could potentially lead to broader insurance
0 Comments
An extensive epidemiological study conducted on the Multi-Ethnic Study of Atherosclerosis (MESA) has revealed a concerning association between the presence of both non-essential and essential metals in urine and an increased risk of cardiovascular disease (CVD) and all-cause mortality. The study, spanning over 17 years, found that various individual urinary metals, including cadmium, tungsten, uranium,
0 Comments
The judge who presided over the class-action lawsuit brought by “Sunday Ticket” subscribers against the NFL criticized the jury for not following his instructions in determining damages. U.S. District Judge Philip Gutierrez expressed his concerns during the NFL’s post-trial motion, where the league requested a ruling in its favor if the plaintiffs failed to prove
0 Comments
In a move to combat the rise of non-consensual fake explicit imagery, Google Search has updated its removal processes and ranking systems. The tech giant’s new strategy aims to swiftly remove explicit deepfakes from its search results and demote websites that host such harmful content. Google has streamlined the process for requesting the removal of
0 Comments
Artificial intelligence continues to showcase its potential in various fields, and one of the recent studies has highlighted its significant impact on predicting Alzheimer’s disease progression. While the skepticism around AI’s storytelling and filmmaking abilities persists, its application in science, particularly in the medical field, is becoming more evident. The study conducted by the University
0 Comments
Meta, formerly known as Facebook, has been making significant investments in artificial intelligence (AI) to drive growth in its core business of digital advertising. The company’s CEO, Mark Zuckerberg, and finance chief, Susan Li, recently highlighted the positive impact of AI on Meta’s revenue growth during their second-quarter earnings call. The Role of AI in
0 Comments